AQR Capital Management’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-953,525
| Closed | -$15.9M | – | 2316 |
|
|
2017
Q3 | $15.9M | Sell |
953,525
-150,892
| -14% | -$2.45M | 0.02% | 647 |
|
|
2017
Q2 | $19.8M | Buy |
1,104,417
+284,907
| +35% | +$5.32M | 0.03% | 601 |
|
|
2017
Q1 | $16.4M | Buy |
819,510
+18,836
| +2% | +$439K | 0.02% | 644 |
|
|
2016
Q4 | $20.1M | Buy |
800,674
+44,032
| +6% | +$1.04M | 0.03% | 601 |
|
|
2016
Q3 | $17.7M | Buy |
756,642
+135,245
| +22% | +$3.18M | 0.03% | 612 |
|
|
2016
Q2 | $12.4M | Buy |
621,397
+122,377
| +25% | +$2.28M | 0.02% | 669 |
|
|
2016
Q1 | $8.45M | Buy |
499,020
+234,890
| +89% | +$4.81M | 0.02% | 719 |
|
|
2015
Q4 | $5.86M | Buy |
264,130
+98,039
| +59% | +$2.04M | 0.01% | 869 |
|
|
2015
Q3 | $2.82M | Sell |
166,091
-10,697
| -6% | -$167K | 0.01% | 994 |
|
|
2015
Q2 | $2.43M | Buy |
176,788
+118,430
| +203% | +$1.57M | ﹤0.01% | 1101 |
|
|
2015
Q1 | $799K | Buy |
58,358
+38,221
| +190% | +$441K | ﹤0.01% | 1513 |
|
|
2014
Q4 | $213K | Sell |
20,137
-3,597
| -15% | -$42.6K | ﹤0.01% | 2341 |
|
|
2014
Q3 | $297K | Hold |
23,734
| – | – | ﹤0.01% | 2184 |
|
|
2014
Q2 | $325K | Hold |
23,734
| – | – | ﹤0.01% | 2180 |
|
|
2014
Q1 | $286K | Hold |
23,734
| – | – | ﹤0.01% | 2284 |
|
|
2013
Q4 | $292K | Buy |
23,734
+1,488
| +7% | +$17.5K | ﹤0.01% | 2311 |
|
|
2013
Q3 | $226K | Buy |
22,246
+546
| +3% | +$5.11K | ﹤0.01% | 2297 |
|
|
2013
Q2 | $195K | Buy |
+21,700
| New | +$219K | ﹤0.01% | 2222 |
|
AQR Capital Management's OME Position: Q4 2017 in Review
AQR Capital Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 953,525 shares — an estimated $15.9M sold.
AQR Capital Management first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $20.1M in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- AQR Capital Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- AQR Capital Management sold 953,525 Omega Protein shares in Q4 2017, an estimated $15.9M.
- AQR Capital Management first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- AQR Capital Management's Omega Protein position peaked at $20.1M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on AQR Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.